Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.
about
Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidatesAttenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm.Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium.Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen.Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.Production of Neisseria meningitidis transferrin-binding protein B by recombinant Bordetella pertussisEnhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria.Surface display of foreign epitopes on the Lactobacillus brevis S-layer.Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.
P2860
Q24657870-96311CD0-EF0E-411A-B03A-35DCC449B722Q30388854-327B7FF1-FD1F-42DC-AA4D-D4A568599B62Q30819553-4638F595-AEF2-4495-9A9E-021EB84EA604Q33725151-D4ED633A-0918-4611-940F-53D30911FAC8Q33768306-C43FAF61-B086-457F-8E44-38A33D05BC87Q33868005-8E68FD36-D592-454D-ABC0-7AFCD3E79659Q34003167-A6661F8A-DAB0-4F7D-884E-77EE9D214B6DQ34006339-68F97D48-85CE-40C3-B1E9-35B34530D402Q34008882-495C2FB1-4169-4993-B12D-9FDD91639421Q37427354-7BD323FD-57C1-4579-A555-8FB6C0C6BB33Q39676828-9FF1C95E-26DD-4EA1-B6FA-D59B7506D10CQ40406131-470F215A-4936-4661-BEC7-E5E6848F2848
P2860
Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Intranasal priming with recomb ...... gainst a heterologous antigen.
@en
Intranasal priming with recomb ...... gainst a heterologous antigen.
@nl
type
label
Intranasal priming with recomb ...... gainst a heterologous antigen.
@en
Intranasal priming with recomb ...... gainst a heterologous antigen.
@nl
prefLabel
Intranasal priming with recomb ...... gainst a heterologous antigen.
@en
Intranasal priming with recomb ...... gainst a heterologous antigen.
@nl
P2093
P2860
P1476
Intranasal priming with recomb ...... against a heterologous antigen
@en
P2093
P2860
P304
P407
P577
1997-02-01T00:00:00Z